Comparative metabolism and DNA binding of aflatoxin B1, aflatoxin M1, aflatoxicol and aflatoxicol-M1 in hepatocytes from rainbow trout (Salmo gairdneri)
- 1 January 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 9 (3) , 441-446
- https://doi.org/10.1093/carcin/9.3.441
Abstract
DNA binding and metabolism patterns of 3H-labeled aflotoxin B1 (AFB1) and its phase I metabolites, aflatoxicol (AFL), aflatoxin M1 (AFM1), and aflatoxicol-M1 (AFL-M1), were compared in freshly prepared rainbow trout (Salmo gairdneri) hepatocytes. Aflatoxins were incubated with hepatocytes for periods up to 1 h, cellular DNA was isolated and specific activities determined by scintillation counting and Burton analysis. Data for (pmol bound aflatoxin/.mu.g DNA)/(.mu.mol dose) versus time fit a linear function (P < 0.002) passing nearly through the origin for each aflatoxin. DNA binding at 1 h relative to AFB1 was: AFL, 0.53 .+-. 0.07; AFM1, 0.81 .+-. 0.20 AFL-M1, 0.83 .+-. 0.24. Statistical analysis indicated that binding of AFL, AFM1 and AFL-M1 were significantly less than of AFB1. HPLC analysis of the cellular supernatants indicated that the major metabolites were AFL, AFB1, AFL-M1, and AFM1 from AFB1, AFL, AFM1 and AFL-M1 substrates, respectively. Small quantities of hydroxylated metabolites and glucuronides also were detected in some of the incubations. The time-course data suggested that initial formation of major metabolites was rapid and that, by 20-30 min, net changes in metabolite levels decreased or approached zero. Because the four compounds possess a 8,9-double bond, DNA binding could be due to activation of the parent substrates as well as of their phase I metabolites. Based on current mutagencity data and limited carcinogenicity studies, AFM1 and AFL-M1 have binding levels which are higher than expected compared to AFB1 and AFL.This publication has 18 references indexed in Scilit:
- Characterisation of the imidazole ring-opened forms of trans-8,9-di-hydro-8-(7-guanyl)9-hydroxy aflatoxin B1Carcinogenesis: Integrative Cancer Research, 1982
- Aflatoxin B1 metabolism and DNA binding in isolated hepatocytes from rainbow trout (Salmo gairdneri)Carcinogenesis: Integrative Cancer Research, 1982
- Carcinogenicity of Aflatoxlcol in Fischer 344 Rats2, 3, 4JNCI Journal of the National Cancer Institute, 1981
- AFLATOXICOL-INDUCED HEPATOCELLULAR-CARCINOMA IN RAINBOW-TROUT (SALMO-GAIRDNERI) AND THE SYNERGISTIC EFFECTS OF CYCLOPROPENOID FATTY-ACIDS1981
- AFLATOXIN-B1 AND AFLATOXICOL METABOLISM IN RAINBOW-TROUT (SALMO-GAIRDNERI) AND THE EFFECTS OF DIETARY CYCLOPROPENE1979
- Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.Proceedings of the National Academy of Sciences, 1977
- COMPARATIVE INVITRO METABOLISM OF AFLATOXICOL BY LIVER PREPARATIONS FROM ANIMALS AND HUMANS1977
- AFLATOXIN B1-2,3-OXIDE AS A PROBABLE INTERMEDIATE IN COVALENT BINDING OF AFLATOXINS B1 AND B2 TO RAT-LIVER DNA AND RIBOSOMAL-RNA INVIVO1977
- Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential.Proceedings of the National Academy of Sciences, 1976
- AFLATOXIN-B1 METABOLISM TO AFLATOXICOL AND DERIVATIVES LETHAL TO BACILLUS-SUBTILIS GSY 1057 BY RAINBOW-TROUT (SALMO-GAIRDNERI) LIVER1976